Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): a retrospective controlled study

PURPOSE: To compare the efficacy and safety of combined treatment with lenvatinib and transarterial chemoembolization (TACE) versus TACE only in patients with unresectable hepatocellular carcinoma (uHCC). METHODS: Of the 120 patients enrolled in this study, 60 patients received treatment with TACE o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hepatol Int
Auteurs principaux: Fu, Zhigang, Li, Xiaowei, Zhong, Jiaming, Chen, Xiaoxia, Cao, Kunkun, Ding, Ning, Liu, Li, Zhang, Xiaoli, Zhai, Jian, Qu, Zengqiang
Format: Artigo
Langue:Inglês
Publié: Springer India 2021
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286947/
https://ncbi.nlm.nih.gov/pubmed/33877527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-021-10184-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires